These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The infectious risks of transfusions in the United States: a decision-analytic approach. Heymann SJ; Brewer TF Am J Infect Control; 1993 Aug; 21(4):174-82. PubMed ID: 8239047 [TBL] [Abstract][Full Text] [Related]
47. [Retrospective transfusional audit at the Centro Nacional de la Transfusión Sanguínea]. Juárez-Rangel E; Vite-Casanova MJ; Marín y López RA; Sánchez-Guerrero SA Rev Invest Clin; 2004; 56(1):38-42. PubMed ID: 15144041 [TBL] [Abstract][Full Text] [Related]
48. Transfusion hazard reporting: powerful data, but do we know how best to use it? Williamson LM Transfusion; 2002 Oct; 42(10):1249-52. PubMed ID: 12423506 [No Abstract] [Full Text] [Related]
49. [Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety]. Cazenave JP Bull Acad Natl Med; 2010 Dec; 194(9):1707-19; discussion 1719-20. PubMed ID: 22043595 [TBL] [Abstract][Full Text] [Related]
50. How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service? Dunbar NM; Dumont LJ; Szczepiorkowski ZM Transfusion; 2016 Jun; 56(6):1262-6. PubMed ID: 27018564 [TBL] [Abstract][Full Text] [Related]
53. Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study. Just SA; Rostgaard K; Titlestad K; Edgren G; Erikstrup C; Ullum H; Pedersen OB; Nielsen KR; Askling J; Lindegaard H; Hjalgrim H Ann Rheum Dis; 2018 Oct; 77(10):1536-1537. PubMed ID: 29496719 [No Abstract] [Full Text] [Related]
54. Blood safety in the developing world and WHO initiatives. Dhingra N Vox Sang; 2002 Aug; 83 Suppl 1():173-7. PubMed ID: 12617131 [No Abstract] [Full Text] [Related]
55. DELAYED HAEMOLYTIC TRANSFUSION REACTION CAUSED BY ANTI-C AND ANTI-E. JORGENSEN JR Dan Med Bull; 1964 Aug; 11():165-8. PubMed ID: 14176124 [No Abstract] [Full Text] [Related]
56. [Experimental research on hemato-medullary changes consequent to repeated transfusions of concentrated homologous erythrocytes in the albino rat]. CORSO F Riv Emoter Immunoematol; 1959; 6():258-70. PubMed ID: 13812108 [No Abstract] [Full Text] [Related]
57. Risk management strategies for HIV in blood transfusion in developing countries. Bharucha ZS Vox Sang; 2002 Aug; 83 Suppl 1():167-71. PubMed ID: 12617130 [No Abstract] [Full Text] [Related]
58. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative. Sharma DK; Datta S; Gupta A Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707 [TBL] [Abstract][Full Text] [Related]
59. [Transfusion safety: state of the arts (ART)]. Ben Romdhane N; Baccouche H; Mahjoub S; Khayati A Tunis Med; 2012 May; 90(5):357-61. PubMed ID: 22585641 [TBL] [Abstract][Full Text] [Related]
60. Blood use strategies in urologic surgery. Gilbert WB; Smith JA Urology; 2000 Apr; 55(4):461-7. PubMed ID: 10736484 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]